BCHE and myasthenia gravis: Currently, the most common therapeutic strategies for MG include the use of cholinesterase inhibitors, corticosteroids, mmunosuppressants, plasmapheresis, intravenous immunoglobulin, monoclonal antibodies or thymectomy (11, 12).